A carregar...
应用聚乙二醇化重组人G-CSF预防淋巴瘤患者化疗后中性粒细胞减少：一项前瞻、多中心、开放性临床研究
OBJECTIVE: To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in prophylaxis neutropenia after chemotherapy in patients with lymphoma. METHODS: This was a multicenter, single arm, open, phase Ⅳ clinical trial. Included 410 patients...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364967/ https://ncbi.nlm.nih.gov/pubmed/29166732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|